SynCardia Systems, Inc. is a private company formed in 2001 to commercialize the SynCardia temporary Total Artificial Heart.Today, with more than 1,000 implants, the SynCardia Total Artificial Heart is the only FDA, Health Canada and CE approved Total Artificial Heart in the world. Originally used as a permanent replacement heart, the Total Artificial Heart is currently approved as a bridge to human heart transplant for people dying from end-stage biventricular failure.